Fibronectin Type III Connecting Segment Fragment 1-25

CAT:
804-HY-P2719
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Fibronectin Type III Connecting Segment Fragment 1-25 - image 1

Fibronectin Type III Connecting Segment Fragment 1-25

  • UNSPSC Description:

    Fibronectin Type III Connecting Segment Fragment 1-25 is a peptide that is responsible for melanoma cell adhesion, and plays an important role in development of the peripheral nervous system in chicken[1][2].
  • Target Antigen:

    Others
  • Type:

    Peptides
  • Related Pathways:

    Others
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/fibronectin-type-iii-connecting-segment-fragment-1-25.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    C([C@@H](NC(=O)[C@H]1N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@H]2N(C([C@@H](NC([C@@H](NC([C@H](CC(O)=O)N)=O)CCC(O)=O)=O)CC(C)C)=O)CCC2)CCC(N)=O)=O)CC(C)C)=O)C(C)C)=O)[C@@H](C)O)=O)CC(C)C)=O)CCC1)CC3=CN=CN3)(=O)N4[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC5=CN=CN5)C(NCC(=O)N6[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N7[C@H](C(N[C@H](C(N[C@@H]([C@@H](C)O)C(O)=O)=O)CO)=O)CCC7)C(C)C)=O)CC(O)=O)=O)CC(C)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCC6)=O)=O)CC(C)C)=O)CC(N)=O)=O)CCC4
  • Molecular Weight:

    2732.05
  • References & Citations:

    [1]A Komoriya, et al. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem. 1991 Aug 15;266(23):15075-9.|[2]M J Humphries, et al. Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment. J Cell Biol. 1988 Apr;106(4):1289-97.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported
  • CAS Number:

    107978-77-8